William Harris Investors’s Antares Pharma, Inc. ATRS Stock Holding History

William Harris Investors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$93K	Hold	40,000	–	–	0.03%	90
2016 Q3	$67K	Sell	40,000 -1,696,256	-98%	-$2.08M	0.02%	85
2016 Q2	$1.82M	Hold	1,736,256	–	–	0.46%	45
2016 Q1	$1.51M	Buy	1,736,256 +113,307	+7%	+$110K	0.38%	42
2015 Q4	$1.96M	Sell	1,622,949 -24,643	-1%	-$34.3K	0.47%	39
2015 Q3	$2.8M	Buy	1,647,592 +113,309	+7%	+$222K	0.79%	40
2015 Q2	$3.19M	Sell	1,534,283 -7,487	-0.5%	-$18.2K	0.89%	37
2015 Q1	$4.18M	Sell	1,541,770 -544,116	-26%	-$1.38M	1.1%	34
2014 Q4	$5.36M	Sell	2,085,886 -197,590	-9%	-$444K	1.38%	32
2014 Q3	$4.18M	Sell	2,283,476 -55,259	-2%	-$120K	1.25%	31
2014 Q2	$6.24M	Buy	2,338,735 +825,000	+55%	+$2.48M	1.73%	29
2014 Q1	$5.3M	Sell	1,513,735 -285,000	-16%	-$1.26M	1.53%	30
2013 Q4	$8.04M	Sell	1,798,735 -25,000	-1%	-$102K	2.38%	19
2013 Q3	$7.4M	Buy	1,823,735 +125,000	+7%	+$546K	2.31%	19
2013 Q2	$7.07M	Buy	+1,698,735	New	+$6.56M	2.15%	23

Other funds holding ATRS

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

William Harris Investors's ATRS Position: Q4 2016 in Review

William Harris Investors held its Antares Pharma, Inc. (ATRS) position steady in Q4 2016 at 40,000 shares worth $93K. The position accounts for 0.03% of the portfolio, ranked #90.

William Harris Investors first reported a position in ATRS in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.04M in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q4 2016.

William Harris Investors held 40,000 shares of Antares Pharma, Inc. worth $93K as of Q4 2016.
William Harris Investors left its Antares Pharma, Inc. share count unchanged in Q4 2016.
Antares Pharma, Inc. made up 0.03% of William Harris Investors's portfolio in Q4 2016, its #90 holding.
William Harris Investors first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 15 quarters since.
William Harris Investors's Antares Pharma, Inc. position peaked at $8.04M in Q4 2013.
71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.